US Broker Ratings

Natera, Inc. (NTRA) Stock Analysis: Evaluating a 34.7% Revenue Growth in the Booming Diagnostics Sector

For investors with a keen interest in the healthcare sector, Natera, Inc. (NASDAQ: NTRA) stands out as a formidable player in the diagnostics and research industry...

Sanofi (SNY) Stock Analysis: A 24.53% Upside Potential Amidst Strong Dividend Yield

Sanofi (NASDAQ: SNY), a titan in the healthcare sector, continues to command the attention of investors with its robust market position in the drug manufacturing industry...

Humana Inc. (HUM) Stock Analysis: Navigating Growth in Healthcare with a 5.54% Upside

Investors looking to secure a foothold in the healthcare sector may find Humana Inc. (HUM) a compelling candidate. Operating at the intersection of insurance and health..

Cencora, Inc. (COR) Stock Analysis: A Robust Healthcare Player with 9.76% Potential Upside

Cencora, Inc. (NYSE: COR), a stalwart in the healthcare sector, stands as a significant player in the medical distribution industry. With a market capitalization of $68.84..

Merck & Company, Inc. (MRK) Stock Analysis: Key Insights on its 4.27% Upside Potential

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to attract investor attention with its robust market presence and promising growth prospects...

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Healthcare Growth with a Diverse Product Portfolio

Investors with a keen eye on the healthcare sector will undoubtedly recognize Becton, Dickinson and Company (NYSE: BDX) as a stalwart in medical instruments and supplies...

Alnylam Pharmaceuticals (ALNY): Growth Potential Highlighted by Robust Pipeline and 36.85% Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, is garnering significant attention from investors due to its innovative approach in developing therapeutics based..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring a $109.81 Billion Market Giant with a 3.92% Potential Upside

HCA Healthcare, Inc. (HCA), a formidable entity in the healthcare sector, operates an expansive network of hospitals and healthcare facilities across the United States. With a..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 16.20% Potential Upside in the Healthcare Sector

Alcon Inc. (ALC), a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling prospect for investors with its innovative..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with 12% Upside Potential

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands out as a robust investment opportunity with a market capitalization of $104.54 billion. This Texas-based..

Cardinal Health, Inc. (CAH) Stock Analysis: Navigating the Healthcare Giant’s 6.82% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) stands out as a major player in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of..

AstraZeneca PLC (AZN) Stock Analysis: Riding a Revenue Growth Wave with a 4.8% Upside Potential

AstraZeneca PLC (NASDAQ: AZN), a leading player in the global healthcare sector, is currently capturing investor attention with its impressive market cap of $292.78 billion and..

Takeda Pharmaceutical Company L (TAK) Investor Outlook: Navigating a 9.69% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK), a giant in the healthcare sector, offers a tantalizing prospect for investors with its 9.69% potential upside. As Japan’s leading..

CVS Health Corporation (CVS) Stock Analysis: Exploring a 20.81% Potential Upside Amid Strong Analyst Ratings

CVS Health Corporation (NYSE: CVS), a leading player in the healthcare plans industry, stands at a pivotal juncture with a market capitalization of $99.78 billion. The..

Boston Scientific Corporation (BSX) Stock Analysis: An Attractive 41% Potential Upside Beckons Investors

Boston Scientific Corporation (NYSE: BSX), a significant player in the healthcare sector, has long been a cornerstone in the medical devices industry. With a market capitalization..

Regeneron Pharmaceuticals (REGN) Stock Analysis: A Biotech Powerhouse with 12.69% Upside Potential

Regeneron Pharmaceuticals, Inc. (REGN), a leading name in the biotechnology sector, continues to capture investor attention with its robust pipeline and strong market presence. Headquartered in..

Amgen Inc. (AMGN) Stock Analysis: Robust Revenue Growth and Strategic Partnerships Propel Investor Interest

Amgen Inc. (AMGN), a titan in the healthcare sector, continues to capture investor attention with its impressive revenue growth and strategic collaborations. As a leading player..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Growth with a Solid Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable presence in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $112.5..

Johnson & Johnson (JNJ) Investor Outlook: Navigating a Solid Healthcare Giant with a Robust 33.62% Return on Equity

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to command attention with its formidable market cap of $526.82 billion. Based in New..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds